Top

Current Urology Reports

Published in:

Open Access 19-09-2023 | Artificial Intelligence

Potential of AI-Driven Chatbots in Urology: Revolutionizing Patient Care Through Artificial Intelligence

Authors: Ali Talyshinskii, Nithesh Naik, B. M. Zeeshan Hameed, Patrick Juliebø-Jones, Bhaskar Kumar Somani

Published in: Current Urology Reports | Issue 1/2024

Abstract

Purpose of Review

Artificial intelligence (AI) chatbots have emerged as a potential tool to transform urology by improving patient care and physician efficiency. With an emphasis on their potential advantages and drawbacks, this literature review offers a thorough assessment of the state of AI-driven chatbots in urology today.

Recent Findings

The capacity of AI-driven chatbots in urology to give patients individualized and timely medical advice is one of its key advantages. Chatbots can help patients prioritize their symptoms and give advice on the best course of treatment. By automating administrative duties and offering clinical decision support, chatbots can also help healthcare providers. Before chatbots are widely used in urology, there are a few issues that need to be resolved. The precision of chatbot diagnoses and recommendations might be impacted by technical constraints like system errors and flaws. Additionally, issues regarding the security and privacy of patient data must be resolved, and chatbots must adhere to all applicable laws. Important issues that must be addressed include accuracy and dependability because any mistakes or inaccuracies could seriously harm patients. The final obstacle is resistance from patients and healthcare professionals who are hesitant to use new technology or who value in-person encounters.

Summary

AI-driven chatbots have the potential to significantly improve urology care and efficiency. However, it is essential to thoroughly test and ensure the accuracy of chatbots, address privacy and security concerns, and design user-friendly chatbots that can integrate into existing workflows. By exploring various scenarios and examining the current literature, this review provides an analysis of the prospects and limitations of implementing chatbots in urology.

Carrillo JE, Carrillo VA, Perez HR, Salas-Lopez D, Natale-Pereira A, Byron AT. Defining and targeting health care access barriers. J Health Care Poor Underserved. 2011;22:562–75. https://doi.org/10.1353/hpu.2011.0037.CrossRefPubMed

Al-Shamsi M. Addressing the physicians’ shortage in developing countries by accelerating and reforming the medical education: is it possible? J Adv Med Educ Prof. 2017;5:210–9.PubMedPubMedCentral

Guttman OT, Lazzara EH, Keebler JR, Webster KLW, Gisick LM, Baker AL. Dissecting communication barriers in healthcare: a path to enhancing communication resiliency, reliability, and patient safety. J Patient Saf. 2021;17:e1465–71. https://doi.org/10.1097/PTS.0000000000000541. PMID: 30418425.CrossRefPubMed

Naik N, Hameed BMZ, Nayak SG, Gera A, Nandyal SR, Shetty DK, et al. Telemedicine and telehealth in urology-what do the ‘patients’ think about it? Front Surg. 2022;9:863576. https://doi.org/10.3389/fsurg.2022.863576.CrossRefPubMedPubMedCentral

Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. https://doi.org/10.1016/j.sintl.2021.100117.CrossRefPubMedPubMedCentral

Palanica A, Flaschner P, Thommandram A, Li M, Fossat Y. Physicians’ perceptions of chatbots in health care: cross-sectional web-based survey. J Med Internet Res. 2019;21:e12887. https://doi.org/10.2196/12887.CrossRefPubMedPubMedCentral

Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB, et al. Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med. 2023;28:e231838. https://doi.org/10.1001/jamainternmed.2023.1838.CrossRef

Adamopoulou E, Moussiades L. An overview of chatbot technology. Artificial Intelligence Applications and Innovations, vol. 584; 2020. pp. 373–83.https://doi.org/10.1007/978-3-030-49186-4_31.

Bernstein DE, Bernstein BS. Urological technology: where will we be in 20 years’ time? Ther Adv Urol. 2018;10:235–42. https://doi.org/10.1177/1756287218782666.CrossRefPubMedPubMedCentral

10.

Temsah O, Khan SA, Chaiah Y, Senjab A, Alhasan K, Jamal A, et al. Overview of early ChatGPT’s presence in medical literature: insights from a hybrid literature review by ChatGPT and human experts. Cureus. 2023;15:e37281. https://doi.org/10.7759/cureus.37281.CrossRefPubMedPubMedCentral

11.

Gabrielson AT, Odisho AY, Canes D. Harnessing generative artificial intelligence to improve efficiency among urologists: welcome ChatGPT. J Urol. 2023;209:827–9. https://doi.org/10.1097/JU.0000000000003383.CrossRefPubMed

12.

Au Yeung J, Kraljevic Z, Luintel A, Balston A, Idowu E, Dobson RJ, Teo JT. AI chatbots not yet ready for clinical use. Front Digit Health. 2023;5:1161098. https://doi.org/10.3389/fdgth.2023.CrossRefPubMedPubMedCentral

13.

Kobori Y, Osaka A, Soh S, Okada H. Novel application for sexual transmitted infection screening with an AI chatbot. J Urol. 2018;199:e189–90. https://doi.org/10.1016/j.juro.2018.02.516.CrossRef

14.

Allen JD, Reich A, Cuevas AG, Ladin K. Preparing African American men to make informed prostate cancer screening decisions: development and pilot testing of an interactive online decision aid. JMIR mHealth uHealth. 2020;8(5):e15502. https://doi.org/10.2196/15502.CrossRefPubMedPubMedCentral

15.

Owens OL, Felder T, Tavakoli AS, Revels AA, Friedman DB, Hughes-Halbert C, et al. Evaluation of a computer-based decision aid for promoting informed prostate cancer screening decisions among African American men: iDecide. Am J Health Promot. 2019;33:267–78. https://doi.org/10.1177/0890117118786866.CrossRefPubMed

16.

Mark JR, McDougall C, Giri VN. Genetic testing guidelines and education of health care providers involved in prostate cancer care. In: Loughlin KR, editor. Prostate Cancer Genetics: Changing the Paradigm of Care. Elsevier inc.; 2021. p. 311–22.

17.

Huri E, Hamid R. Technology-based management of neurourology patients in the COVID-19 pandemic: is this the future? A report from the International Continence Society (ICS) institute. Neurourol Urodyn. 2020;39:1885–8. https://doi.org/10.1002/nau.24429.CrossRefPubMedPubMedCentral

18.

Wang H, Gupta S, Singhal A, Muttreja P, Singh S, Sharma P, et al. An artificial intelligence chatbot for young people’s sexual and reproductive health in India (SnehAI): instrumental case study. J Med Internet Res. 2022;24:e29969. https://doi.org/10.2196/29969.CrossRefPubMedPubMedCentral

19.

Görtz M, Baumgärtner K, Schmid T, Muschko M, Woessner P, Gerlach A, et al. An artificial intelligence-based chatbot for prostate cancer education: design and patient evaluation study. Digit Heal. 2023;9:205520762311733. https://doi.org/10.1177/20552076231173304.CrossRef

20.

Khawam, et al. ClinicalTrials.gov. Improving care for women with urinary incontinence (EMPOWER). 2022. https://clinicaltrials.gov/ct2/show/NCT05515198?term=chatbot+urology&draw=2&rank=3. Accessed 15 Jan 2023.

21.

Ray R, Agar Z, Dutta P, Ganguly S, Sah P, Roy D. MenGO: a novel cloud-based digital healthcare platform for andrology powered by artificial intelligence, data science & analytics, bioinformatics and blockchain. Biomed Sci Instrum. 2021. https://doi.org/10.34107/KSZV7781.10476.

22.

Kim EK, Brown LA, Seltzer EK, Hartzell-Leggin D, Borodyanskaya YL, Andy UU, et al. Development of a patient-centered text message-based platform for the self-management of interstitial cystitis/bladder pain syndrome symptoms. Neurourol Urodyn. 2023;42:510–22. https://doi.org/10.1002/nau.25115.CrossRefPubMed

23.

Chen, et al. ClinicalTrials.gov. The impact of chatbot-aid on promoting self-management of men’s health in the post COVID-19 era. 2023. https://clinicaltrials.gov/ct2/show/NCT05765331. Accessed 15 Jan 2023.

24.

Kim Y, Kim JH, Kim YM, Song S, Joo HJ. Predicting medical specialty from text based on a domain-specific pre-trained BERT. Int J Med Inform. 2023;170:104956. https://doi.org/10.1016/j.ijmedinf.2022.104956.CrossRefPubMed

25.

Goldenthal SB, Portney D, Steppe E, Ghani K, Ellimoottil C. Assessing the feasibility of a chatbot after ureteroscopy. mHealth. 2019;5:8. https://doi.org/10.21037/mhealth.2019.03.01.

26.

Bennion MR, Hardy GE, Moore RK, Kellett S, Millings A. Usability, acceptability, and effectiveness of web-based conversational agents to facilitate problem solving in older adults: controlled study. J Med Internet Res. 2020;22:e16794. https://doi.org/10.2196/16794.CrossRefPubMedPubMedCentral

27.

Jungwirth D, Haluza D. Artificial intelligence and public health: an exploratory study. Int J Environ Res Public Health. 2023;20:4541. https://doi.org/10.3390/ijerph20054541.CrossRefPubMedPubMedCentral

28.

Lee P, Bubeck S, Petro J. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med. 2023;388:1233–9. https://doi.org/10.1056/NEJMsr2214184.CrossRefPubMed

29.

Calvo RA, Peters D, Moradbakhti L, Cook D, Rizos G, Schuller B, et al. Assessing the feasibility of a text-based conversational agent for asthma support: protocol for a mixed methods observational study. JMIR Res Protoc. 2023;12:e42965. https://doi.org/10.2196/42965.CrossRefPubMedPubMedCentral

30.

Ferré F, Laurent R, Furelau P, Doumard E, Ferrier A, Bosch L, et al. Perioperative risk assessment of patients using the MyRISK digital score completed before the preanesthetic consultation: prospective observational study. JMIR Perioper Med. 2023;6:e39044. https://doi.org/10.2196/39044.CrossRefPubMedPubMedCentral

31.

Han JW, Park J, Lee H. Analysis of the effect of an artificial intelligence chatbot educational program on non-face-to-face classes: a quasi-experimental study. BMC Med Educ. 2022;22:830. https://doi.org/10.1186/s12909-022-03898-3.CrossRefPubMedPubMedCentral

32.

Chetlen A, Artrip R, Drury B, Arbaiza A, Moore M. Novel use of chatbot technology to educate patients before breast biopsy. J Am Coll Radiol. 2019;16:1305–8. https://doi.org/10.1016/j.jacr.2019.05.050.CrossRefPubMed

33.

Wilson L, Marasoiu M. The development and use of chatbots in public health: scoping review. JMIR Hum Factors. 2022;9:e35882. https://doi.org/10.2196/35882.CrossRefPubMedPubMedCentral

34.

Divya S, Indumathi V, Ishwarya S, Priyasankari M. A self-diagnosis medical chatbot using artificial intelligence. J Web Develop Web Design. 2018;3:1–7. https://doi.org/10.1007/978-981-15-6707-0_57.CrossRef

35.

• Soni H, Ivanova J, Wilczewski H, Bailey A, Ong T, Narma A, et al. Virtual conversational agents versus online forms: patient experience and preferences for health data collection. Front Digit Health. 2022;4:954069. https://doi.org/10.3389/fdgth.2022.954069. Paper studying patient preferences for data collection.

36.

Geoghegan L, Scarborough A, Wormald JCR, Harrison CJ, Collins D, Gardiner M, et al. Automated conversational agents for post-intervention follow-up: a systematic review. BJS open. 2021;5:zrab070. https://doi.org/10.1093/bjsopen/zrab070.CrossRefPubMedPubMedCentral

37.

Abd-Alrazaq A, Safi Z, Alajlani M, Warren J, Househ M, Denecke K. Technical metrics used to evaluate health care chatbots: scoping review. J Med Internet Res. 2020;22:e18301. https://doi.org/10.2196/18301.CrossRefPubMedPubMedCentral

38.

Fan X, Chao D, Zhang Z, Wang D, Li X, Tian F. Utilization of self-diagnosis health chatbots in real-world settings: case study. J Med Internet Res. 2021;23(1):e19928. https://doi.org/10.2196/19928.CrossRefPubMedPubMedCentral

39.

May R, Denecke K. Security, privacy, and healthcare-related conversational agents: a scoping review. Inform Health Soc Care. 2022;47:194–210. https://doi.org/10.1080/17538157.2021.1983578.CrossRefPubMed

40.

•• Shahriar S, Hayawi K. Let’s have a chat! A conversation with ChatGPT: technology, applications, and limitations. 2023. arXiv:2302.13817. https://doi.org/10.48550/arXiv.2302.13817. Update on applications of ChatGPT.

41.

Ben-Shabat N, Sharvit G, Meimis B, Ben Joya D, Sloma A, Kiderman D, et al. Assessing data gathering of chatbot based symptom checkers - a clinical vignettes study. Int J Med Inform. 2022;168:104897. https://doi.org/10.1016/j.ijmedinf.2022.104897.CrossRefPubMedPubMedCentral

42.

• Salvagno M, Taccone FS, Gerli AG. Can artificial intelligence help for scientific writing? Crit Care. 2023;27:75. https://doi.org/10.1186/s13054-023-04380-2. Overview of how AI can be used for scientific writing.CrossRefPubMedPubMedCentral

43.

Nadarzynski T, Miles O, Cowie A, Ridge D. Acceptability of artificial intelligence (AI)-led chatbot services in healthcare: a mixed-methods study. Digit Health. 2019;5:2055207619871808. https://doi.org/10.1177/2055207619871808.CrossRefPubMedPubMedCentral

Title: Potential of AI-Driven Chatbots in Urology: Revolutionizing Patient Care Through Artificial Intelligence
Authors: Ali Talyshinskii
Nithesh Naik
B. M. Zeeshan Hameed
Patrick Juliebø-Jones
Bhaskar Kumar Somani
Publication date: 19-09-2023
Publisher: Springer US
Keywords: Artificial Intelligence
Care
Prostate Cancer
Prostate Cancer
Published in: Current Urology Reports / Issue 1/2024
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-023-01184-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Potential of AI-Driven Chatbots in Urology: Revolutionizing Patient Care Through Artificial Intelligence

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content